{"id":946,"date":"2018-11-21T15:07:04","date_gmt":"2018-11-21T13:07:04","guid":{"rendered":"https:\/\/www.movementdisorders.ch\/index\/?page_id=946"},"modified":"2020-02-29T17:14:02","modified_gmt":"2020-02-29T15:14:02","slug":"information","status":"publish","type":"page","link":"https:\/\/www.movementdisorders.ch\/index\/information\/","title":{"rendered":"Professional Information on Movement Disorders"},"content":{"rendered":"

Professional Information on Movement Disorders<\/h2><\/h2><\/div>
<\/div>
<\/div><\/div>
<\/div>
<\/div><\/div><\/div>

Parkinson’s disease and other disorders associated with parkinsonism<\/h3>\n

<\/h4>\n

Parkinson\u2019s Disease<\/h4>\n

diagnostic criteria<\/a>
\nParkinson’s dementia: diagnostic criteria<\/a>
\nguidelines for treatment (I)<\/a>
\nguidelines for treatment (II)<\/a>
\nrating scales<\/a><\/p>\n

guidelines for occupational therapy: Guidelines_OT_Parkinson’s disease_2012<\/a>;<\/p>\n

guidelines for physiotherapy: Parkinson_Leitlinie_Physiotherapeuten_2015<\/a><\/p>\n

physiotherapists: CAS_certified_physiotherapists_2020<\/a><\/p>\n


\n<\/strong>MSA<\/h4>\n

diagnostic criteria, guidelines for treatment<\/a>
\nrating scales<\/a><\/p>\n


\n<\/strong>PSP<\/h4>\n

diagnostic criteria<\/a><\/p>\n<\/div>

<\/div>
<\/div>
<\/div>

CBD<\/h4>\n

diagnostic criteria<\/a>
\nguidelines for treatment of CBD and PSP<\/a><\/p>\n


\n<\/strong>Vascular parkinsonism<\/h4>\n

diagnostic criteria, guidelines for treatment<\/a><\/p>\n<\/div>

<\/div><\/div><\/div>

Essential Tremor<\/h3>\n

diagnostic criteria<\/a>
\nguidelines for treatment<\/a><\/p>\n<\/div>

<\/div>
<\/div>
<\/div>

Dystonia<\/h3>\n

diagnostic criteria, guidelines for treatment, rating scales<\/a><\/p>\n<\/div>

<\/div>
<\/div>
<\/div>

Myoclonus<\/h3>\n

Myoclonus (<\/span>Handbook of Clinical Neurology)<\/a><\/p>\n

Myoclonus in the critically ill: Diagnosis, management, and clinical impact<\/span><\/a><\/p>\n<\/div>

<\/div>
<\/div>
<\/div>

Chorea, Ballism and Huntington’s Disease<\/h3>\n

guidelines for treatment<\/a><\/p>\n<\/div>

<\/div><\/div><\/div>

Restless Legs Syndrom<\/h3>\n

guidelines for treatment<\/a>
\nrating scales<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>

Ataxias<\/h3>\n

classification
\nguidelines for genetic testing, availability of tests<\/a><\/p>\n<\/div>

<\/div>
<\/div>
<\/div>

Spasticity<\/h3>\n

guidelines for treatment<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>

Paroxysmal and other movement disorders (psychogenic, psychiatric, drug-induced)<\/h3>\n

diagnostic criteria, guidelines for treatment<\/p>\n<\/div>

<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-946","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.movementdisorders.ch\/index\/wp-json\/wp\/v2\/pages\/946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.movementdisorders.ch\/index\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.movementdisorders.ch\/index\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.movementdisorders.ch\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.movementdisorders.ch\/index\/wp-json\/wp\/v2\/comments?post=946"}],"version-history":[{"count":13,"href":"https:\/\/www.movementdisorders.ch\/index\/wp-json\/wp\/v2\/pages\/946\/revisions"}],"predecessor-version":[{"id":1171,"href":"https:\/\/www.movementdisorders.ch\/index\/wp-json\/wp\/v2\/pages\/946\/revisions\/1171"}],"wp:attachment":[{"href":"https:\/\/www.movementdisorders.ch\/index\/wp-json\/wp\/v2\/media?parent=946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}